Financial Snapshot

Revenue
$162.5M
TTM
Gross Margin
35.89%
TTM
Net Earnings
-$166.4M
TTM
Current Assets
Q3 2023
Current Liabilities
Q3 2023
Current Ratio
273.19%
Q3 2023
Total Assets
Q3 2023
Total Liabilities
Q3 2023
Book Value
-$50.57M
Q3 2023
Cash
Q3 2023
P/E
-0.03044
Jun 25, 2024 EST
Free Cash Flow
-$133.0M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $5.0669 Million

About NS Wind Down Co., Inc.

NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. The company is headquartered in Seattle, Washington and currently employs 703 full-time employees. The company went IPO on 2013-06-26. The company develops, manufactures, and markets technologies of biological materials for life science researchers in the fields of genomics and proteomics. Its product platforms include nCounter Analysis System (nCounter), CosMx Spatial Molecular Imager, AtoMx Spatial Informatics Platform, and GeoMx Digital Spatial Profiler (GeoMx DSP). Its nCounter is a multi-application, digital detection and counting system which directly profiles hundreds of molecules simultaneously, using optical barcoding chemistry. Its nCounter platform is based on automated instruments that prepare and analyze biological samples using reagents. GeoMx DSP is used to analyze selected regions of an intact biological sample without the need to break down the sample, enabling researchers to see how gene expression might vary across those regions. Its CosMx Spatial Molecular Imager is a spatial biology product platform.

Industry: Biological Products, (No Diagnostic Substances) Peers: Adaptive Biotechnologies Corp NEOGENOMICS INC Bionano Genomics, Inc. SomaLogic, Inc. Cytek Biosciences, Inc. MAXCYTE, INC. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Seer, Inc. Sotera Health Co THERMO FISHER SCIENTIFIC INC.